Radiation exposure triggers the progression of triple negative breast cancer via stabilizing ZEB1

被引：8
|
作者：
Lin, Yu [1 ]
Bai, Xia [2 ]
Zhou, Weina [2 ]
He, Yulin [2 ]
Wu, Yiwei [3 ]
Wang, Xiangcheng [2 ]
机构：
[1] Inner Mongolia Med Univ, Dept Ontol Radiotherapy, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China
[2] Inner Mongolia Med Univ, Dept Nucl Med, Affiliated Hosp, Hohhot 010050, Inner Mongolia, Peoples R China
[3] Soochow Univ, Affiliated Hosp 1, Dept Nucl Med, Suzhou 215000, Jiangsu, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2018年 / 107卷
关键词：
Radiation; TNBC; ZEB1; ATM; Migration; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; CELLS; CARCINOMA; RADIOTHERAPY; EXPRESSION; STRATEGIES; INVASION; PATHWAY; EMT;
D O I：
10.1016/j.biopha.2018.08.026
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, Slug or Twist. Knockdown of ZEB1 attenuated radiation induced cell migration and invasion, suggesting that ZEB1 is essential for radiation induced progression of TNBC. Radiation increased the protein stability of ZEB1, while had no effect on its mRNA expression. Particularly, the upregulation of ATM, which can phosphorylate and stabilize ZEB1, was involved in radiation induced upregulation of ZEB1. Collectively, we found that radiation can promote the migration, invasion and EMT of TNBC cells through stabilization of ZEB1 via ATM signals.
引用
收藏
页码：1624 / 1630
页数：7
相关论文
共 50 条
  • [31] DLAT promotes triple-negative breast cancer progression via YAP1 activation
    Liu, Diya
    Wang, Xuehui
    Qian, Fengyuan
    Ye, Danrong
    Deng, Xiaochong
    Fang, Lin
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [32] TRIM9 Interacts with ZEB1 to Suppress Esophageal Cancer by Promoting ZEB1 Protein Degradation via the UPP Pathway
    Lin, Zhaoxian
    Huang, Jianyuan
    Zhu, Lihuan
    Lin, Xing
    Huang, Yangyun
    Chen, Chun
    Pan, Xiaojie
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [33] SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer
    Zhang, Lei
    Yuan, Chenwei
    Peng, Jing
    Zhou, Liheng
    Jiang, Yiwei
    Lin, Yanping
    Yin, Wenjin
    Xu, Shuguang
    Ma, Jun
    Lu, Jinsong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [34] Mitochondrial reprogramming in triple negative breast cancer progression
    Park, Junhyoung
    Arora, Kavisha
    Vithayathil, Sajna A.
    Donti, Taraka R.
    Creighton, Chad
    Lewis, Michael T.
    Sreekumar, Arun
    Wong, Lee-Jun
    Kaipparettu, Benny A.
    CANCER RESEARCH, 2014, 74 (19)
  • [35] Tunicamycin inhibits triple negative breast cancer progression
    Banerjee, Aditi
    Duran, Elizabeth
    Couto, Javier A.
    Zhang, Zhenbo
    Espinoza, Lydia A.
    Banerjee, Sushanta K.
    Baksi, Krishna
    Banerjee, Dipak K.
    CANCER RESEARCH, 2011, 71
  • [36] MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer
    Guo, S. -J.
    Zeng, H. -X.
    Huang, P.
    Wang, S.
    Xie, C. -H.
    Li, S. -J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (19) : 6379 - 6385
  • [37] Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome
    Jang, Min Hye
    Kim, Hyun Jeong
    Kim, Eun Joo
    Chung, Yul Ri
    Park, So Yeon
    HUMAN PATHOLOGY, 2015, 46 (09) : 1267 - 1274
  • [38] Opposite Roles for ZEB1 and TMEJ in the Regulation of Breast Cancer Genome Stability
    Prodhomme, Melanie K.
    Pericart, Sarah
    Pommier, Roxane M.
    Morel, Anne-Pierre
    Brunac, Anne-Cecile
    Franchet, Camille
    Moyret-Lalle, Caroline
    Brousset, Pierre
    Puisieux, Alain
    Hoffmann, Jean-Sebastien
    Tissier, Agnes
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [39] Synergistic antitumor effects of Peiminine and Doxorubicin on breast cancer through enhancing DNA damage via ZEB1
    Xu, Jiajin
    Zhang, Zeyi
    Hu, Hongtao
    Yang, Yaqin
    Xiao, Chenghong
    Xi, Luyi
    Lu, Jiahui
    Tian, Shasha
    Zhao, Huajun
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [40] Meso-Hannokinol inhibits breast cancer bone metastasis via the ROS/JNK/ZEB1 axis
    Zhu, Yuan
    Yin, Wei-feng
    Yu, Pei
    Zhang, Chao
    Sun, Ming-hui
    Kong, Ling-yi
    Yang, Lei
    PHYTOTHERAPY RESEARCH, 2023, 37 (06) : 2262 - 2279
12345